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ABSTRACT
WehavedevelopedanautomatedSELEX(Systematic
Evolution of Ligands by EXponential Enrichment)
process that allows the execution of in vitro selection
cycles without any direct manual intervention steps.
The automated selection protocol is designed to
provide for high flexibility and versatility in terms of
choice of buffers and reagents as well as stringency
of selection conditions. Employing the automated
SELEX process, we have identified RNA aptamers
to the mirror-image configuration (D-peptide) of sub-
stance P. The peptide substance P belongs to the
tachykinin family and exerts various biologically
important functions, such as peripheral vasodilation,
smooth muscle contraction and pain transmission.
The aptamer that was identified most frequently
was truncated to the 44mer SUP-A-004. The mirror-
image configuration of SUP-A-004, the so-called
Spiegelmer, has been shown to bind to naturally
occurring L-substance P displaying a Kd of 40 nM
and to inhibit (IC50 of 45 nM) L-substance P-mediated
Ca
21 release in a cell culture assay.
INTRODUCTION
In vitro selection of nucleic acids, SELEX (Systematic Evolu-
tion of Ligands by EXponential Enrichment), is a powerful
evolutionary selectionmethod foridentifyingoligonucleotides
with new properties from combinatorial libraries (1). Oligo-
nucleotides with target-binding properties are called aptamers
(2). In terms of afﬁnity and speciﬁcity, aptamers are com-
parable with monoclonal antibodies (3,4). The SELEX
process involves multiple rounds of alternating selection and
ampliﬁcation steps in order to successively enrich aptamer
sequences that show the desired properties. In each round,
the nucleic acid library is contacted with the target,
non-binding molecules are discarded, and binders are ampli-
ﬁed by PCR; if SELEX is carried out with RNA, additional
steps of reverse transcription and enzymatic RNA synthesis
are needed to close each SELEX round. Most enzymatic reac-
tion steps as well as the isolation of binding molecules are
followed by puriﬁcation procedures. Typically, between 8 and
20 selection rounds are necessary until no further enrichment
of functional nucleic acid species is detectable, making the
whole process time-consuming and tedious. The ﬁrst auto-
mated selection protocol based on a Biomek 2000 pipetting
robot (Beckman Coulter) was published in 1998 (5), followed
by modiﬁcations and improvements (6–8). Other suggestions
for a parallel processing of selection experiments were made
by Drolet et al. (9). The reported procedures are primarily
designed for the high-throughput generation of aptamers,
and for this reason, complex and sophisticated selection pro-
tocols are difﬁcult to implement on these automated systems.
We have developed an automated selection protocol that is
designed to be as close as possible to manual in vitro selection.
Special emphasis was placed on ﬂexible routines that offer the
possibilitytoadjuststringency orvaryincubationtimesaswell
as on an online monitoring of the ampliﬁcation step. Adjust-
able parameters and online monitoring allow for a very reli-
able process for the identiﬁcation of highly afﬁne aptamers.
Substance P served as an appropriate target for demonstrat-
ing the robustness of our automated in vitro selection process.
Substance P is an 11 amino acid peptide that belongs to the
tachykinin family. It is released from both the central and
peripheral endings of primary afferent neurons and acts as a
neurotransmitter. The peptide was ﬁrst identiﬁed by bioassays
as early as 1931, and was one of the most extensively studied
bioactive substances during the half-century since its discov-
ery. Surprisingly, the amino acid sequence was not determined
until 1971 (10–12). Substance P may be considered as the
prototype of the tachykinins, neurotransmitters that have
been implicated to have a wide variety of biological activities,
such as peripheral vasodilation, smooth muscle contraction,
pain transmission (nociception), activation of the immune
system and neurogenic inﬂammation (12). Mammalian
*To whom correspondence should be addressed. Tel: +49 30 726247 240; Fax: +49 30 726247 243; Email: sklussmann@noxxon.net
ª The Author 2005. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
areattributedastheoriginalplaceofpublicationwiththecorrectcitationdetailsgiven;ifanarticleissubsequentlyreproducedordisseminatednotinitsentiretybut
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
Nucleic Acids Research, 2005, Vol. 33, No. 4 e45
doi:10.1093/nar/gni044tachykinins known to date include substance P, neurokinin A
(neurokinin a, neuromedin L, substance K) and B (neurokinin
b, neuromedin K), and hemokinin 1 as well as the recently
discovered endokinins A, B, C and D, which are apparently
translated from four splice variants of the human TAC4 gene
(13). Neurokinin A is also present in two elongated forms,
neuropeptide K and neuropeptide-g. Three tachykinin receptor
types could be identiﬁed, all of which are G-protein-coupled:
NK1,N K 2 and NK3. Substance P, hemokinin 1 and endokinin
A and B show preference for NK1 (13–15), neurokinin A for
NK2 and neurokinin B for NK3. However, these tachykinins
are not highly selective and can act on all three receptors.
Endokinin C and D have only weak activity at the known
receptors, indicating that their receptor(s) remain to
be elucidated (13).
Substance P has been the target of an in vitro selection
earlier, resulting in an RNA aptamer with a dissociation con-
stant of 190 nM (16). In order to obtain a potent nuclease-
resistant, oligonucleotide-based substance P antagonist with
potential therapeutic value, a mirror-image selection process
was employed (17,18). For this purpose, ﬁrst a regular
nucleic acid library is used to isolate aptamers that bind to
the D-enantiomer of the naturally occurring peptide target.
Subsequently, the aptamer sequence is synthesized in its
mirror-image conﬁguration, resulting in an L-RNA ligand,
a so-called Spiegelmer. Following the principles of chirality,
the Spiegelmer binds to the naturally occurring L-peptide
target, in this case substance P.
In this paper, we describe the automated generation of a
highly afﬁne substance P antagonist that is based on a mirror-
image RNA sequence. The antagonist was biophysically char-
acterized and able to effectively inhibit substance P-mediated
Ca
++ mobilization in cells expressing the NK1 receptor.
MATERIALS AND METHODS
Materials
The initial single-stranded DNA (ssDNA) library, primers,
truncated aptamers and Spiegelmers were synthesized using
standard phosphoramidite chemistry. A combinatorial RNA
library of  10
15 different molecules was obtained by enzym-
atic conversion of 3 nmol of a synthetic DNA library (ssDNA
pool, 30-CACCTTGGCTGAGTGGACTCGCACG-N34-CGT-
GCGACGACAACAGATTCGAGG-50; forward primer with
underlined T7 promoter, 50-TCTAATACGACTCACTATAG-
GAGCTTAGACAACAGCAG-30; reverse primer, 50-GTGG-
AACCGACTCACCTGAG-30) into double-stranded DNA
(dsDNA), which was then transcribed into RNA using T7
RNA polymerase (50-GGAGCUUAGACAACAGCAGCGU-
GC-N34-GCACGCUCAGGUGAGUCGGUUCCAC-30). This
starting pool was initially labelled with [a-
32P]GTP during
in vitro transcription. All L- and D-peptides were obtained
from BACHEM AG, Switzerland (Table 1). For in vitro selec-
tion, D-substance P with C-terminally attached biotin was
used. For capture of D-substance P-biotin RNA complexes,
NeutrAvidin Agarose and Streptavidin Ultralink particles
(Pierce) were used. PicoGreen for dsDNA assessment during
semi-quantitative PCR was purchased from Molecular Probes
(Eugene, OR). The non-functional control Spiegelmer used
in isothermal titration calorimetry (ITC) measurements and
cell-culture assays had the sequence 50-UAAGGAAACUCG-
GUCUGAUGCGGUAGCGCUGUGCAGAGCU-30.
Robot configuration and software
All automated liquid and mechanical manipulations were car-
ried out using a RoboAmp 4200 E instrument (MWG Biotech,
Ebersberg, Germany). The robot was augmented with cooled
and heated storage racks and workstations, a hotel for storage
of microtiter plates and a custom-designed double vacuum
manifold for partitioning and RNA puriﬁcation, respectively.
In order to avoid cross-contamination between samples, sam-
ple evaporation during prolonged incubation times or storage
and dilution of cooled reagents by condensing water, the robot
was equipped with the NCC (‘non-cross-contamination’) sys-
tem from MWG, which consists of plasticware with individual
lids on each well and an automatic lid manipulator. Details are
depicted in Figure 1A.
The whole robot with its periphery was placed under a
temperature-controlled hood, which allowed performance
of the selection process at 37 C (Figure 1B). The script con-
trolling the robot was written in Robomanager version 4.0.8
(MWG Biotech).
Initial selection rounds
The maximum amount of matrix material for immobilization
of biotinylated peptide that can be handled on the automated
platform is  10 ml, which allows for up to 10 mM target
concentration in our system. We decided to start the selection
with a target concentration of 30 mM; accordingly, the initial
rounds were performed manually. Manual selection rounds
were carried out as outlined below, with the following differ-
ences: round 1 was at 25 C; elution was not executed by
thermal denaturation, but by incubating the matrix with
captured substance P RNA complexes in 4 M guanidine iso-
thiocyanate twice for 10 min at 37 C and 65 C, respectively.
Combined eluates were phenol–chloroform extracted and
ethanol precipitated. RT–PCR was run with Superscript II
Reverse Transcriptase, and for PCR, Taq DNA polymerase
was used (Invitrogen, Karlsruhe, Germany). Finally, tran-
scripts were puriﬁed by denaturing PAGE.
Process of automated in vitro selection
During automated in vitro selection, most liquid handling
manipulations were performed in 96-well plates with remov-
able lids; partitioning of unbound from bound RNA species
wascarriedoutinMobicolcolumns(MoBiTecAG,Go ¨ttingen,
Germany); for automated transcript puriﬁcation, Microcon
ultraﬁltration units were employed (Millipore, Eschborn,
Germany). Automated ﬂuorescent measurements for
Table 1. Peptides used in the study
Peptide Chirality Sequence
Substance P-biotin D RPKPQQFFGLM-biotin
Substance P L RPKPQQFFGLM-NH2
Substance P1–7 L RPKPQQF-OH
Substance P5–11 L QQFFGLM-NH2
Neurokinin A L HKTDSFVGLM-NH2
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bottom plates (Costar).
Input used for the automated selection. RNA for the ﬁrst
automated selection round (round 4) was obtained after
three manual selection rounds. Aliquots containing 250 pmol
of this RNA were used as input in the binding reactions of
round 4 and 5, 200 pmol for round 6 and 7, and 100 pmol in
every further round.
Denaturation of RNA. All non-enzymatic selection steps
except denaturation of the RNA before contacting with the
target molecule (biotinylated D-substance P) were performed
in selection buffer (20 mM Tris–HCl, pH 7.4, 150 mM NaCl,
5 mM KCl, 1 mM MgCl2, 1 mM CaCl2 and 0.1% Tween-20).
RNA denaturing and re-folding was achieved by incubating
at 95 C for 5 min in 57 ml selection buffer without CaCl2 and
MgCl2. After denaturation, the RNA was quickly cooled to
4 C for 2 min and then equilibrated at 37 C. CaCl2 and MgCl2
were added to ﬁnal concentrations of 1 mM each, and the
mixture was incubated at 37 C for RNA folding.
Partitioning of bound from unbound RNA. Following dena-
turation, the RNA was contacted for 15 min at 37 C with 10 ml
of the selection matrix (NeutrAvidin agarose or NeutrAvidin
UltraLink) without peptide. This so-called pre-selection was
designed to remove potential matrix-binding RNA species
from the library. The RNA of the supernatant was separated
from the matrix by transferring it to fresh wells on the same
plate.Differentamountsoftargetwereadded totheRNAtoset
up three different binding reactions. A fourth sample of the
RNA pool was contacted with binding buffer only and served
as a control reaction. After thorough mixing by pipetting up
and down, the binding reactions were incubated for 60 min.
A
B
Figure 1. The selection robot. (A) Picture of the RoboAmp robot with accessories under a temperature-controlled hood. (B) Schematic work surface used for the
selection; numbers refer to the participation of workstations during the selection as depicted in Figure 2B.
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by adding biotin capture matrix and shaking the plate for
7 min. The mixture was transferred into column-like plastic
tubeswithanoutletandaplastic frit,which hadbeenﬁttedinto
vacuum manifold A. By applying gentle vacuum, the liquid
was separated from the matrix with bound substance P RNA
complexes. The matrix particles were washed with selection
buffer, followed by its removal under vacuum. Depending on
the selection round, between 2 and 15 wash cycles were per-
formed, which correspond to 18–135 column volumes. The
washed matrix particles were resuspended in 120 ml RT–PCR
buffer (Qiagen One Step RT–PCR kit) and transferred into
fresh wells of the 96-well plate. The RNA was eluted from the
matrix by incubating the plate for 15 min at 95 C.
RT and semi-quantitative PCR. Prior to the RT reaction, the
96-well plate was transferred to the 50 C workstation to equi-
librate the reaction mixture. According to the manufacturer’s
protocol, RT–PCR enzyme mixture was injected into the wells
and incubated for 20 min at 50 C. The plate was then trans-
ferred to the thermocycler, incubated for further 10 min at
60 C, and 15 min at 95 C. Thermocycling was processed
for 30 s at 95 C, 30 s at 63 C and 30 s at 72 C, with the last
polymerization step extended to 2 min. The plate was trans-
ferred to the 50 C workstation after cycles 7, 10, 13 and 16.
Aliquots containing 3 ml of each reaction were mixed with
180 ml of a 1:400 dilution of PicoGreen (Molecular Probes) in
TE buffer, pH 8 (10 mM Tris–HCl and 1 mM EDTA), which
was previously ﬁlled into a black 96-well microtiter plate.
PicoGreen is a ﬂuorescent dye that shows only weak ﬂuore-
scence when free in solution. If the dye binds to dsDNA, it
ﬂuoresces strongly (ex: 485 nm; em: 520 nm). Measurement
of ﬂuorescence in comparison with a blank lacking the
thermostable polymerase allows a satisfactory estimation of
the PCR progress. After reaching the set threshold (ﬂuore-
scence intensity with polymerase/ﬂuorescence intensity
without ﬂuorescence >2), the respective reaction was auto-
matically removed from the plate and pipetted into a storage
plate at 4 C before the reaction plate was transferred
back to the thermocycler again. Aliquots of the archived
dsDNA were used for in vitro transcription without further
puriﬁcation.
In vitro transcription and transcript purification. Aliquots
containing 30 ml of the RT–PCR were added to 116 mlT 7
mastermix, which was previously ﬁlled into fresh wells of the
reaction plate (ﬁnal concentrations in the T7 reactions, 80 mM
HEPES, pH 7.5, 22 mM MgCl2, 1 mM spermidine, 10 mM
DTT, 4 mM GTP, ATP, CTP and UTP, 80 mg/ml BSA) not
accounting for the reagents contained in the RT–PCR aliquot.
The reactions were started by the addition of 3 ml5 0U / mlT 7
RNA polymerase (Stratagene, Heidelberg, Germany) plus 1 ml
RNaseOut RNase inhibitor (Invitrogen) and incubated for
180 min at 37 C. The dsDNA template was then digested
with  1 U DNase I for 15 min at 37 C, followed by heat
denaturation for 5 min at 95 C in the thermocycler. The tran-
scription reactions were then transferred to Microcon ultra-
ﬁltration units which were ﬁtted onto vacuum manifold B. By
application of vacuum, the membrane was then sucked dry.
H2O was added to remove residual low molecular weight
impurities, and after 40 min, the vacuum was switched off.
Finally, the retained RNA was resuspended in 100 ml water.
For the next round, 10 ml of the RNA was used, and the rest
was archived on the 4 C workstation.
Pull-down assays
Pools resulting from different selection rounds as well as indi-
vidualcloneswere rankedinrespectoftheirbindingbehaviour
to biotinylated D-substance P. For this purpose, the respective
dsDNAs were transcribed in the presence of [a-
32P]GTP. Ali-
quots containing 2–5 pmol of the radiolabelled RNAs were
denatured and refolded as described above. The oligonuc-
leotides were then incubated in a volume of 1 ml selection
buffer for 1 h at 37 C with 30, 100 and 300 nM biotinylated
D-substance P. Subsequently, 10 ml of NeutrAvidin agarose
was added for immobilization and was incubated under con-
stant shaking for further 10 min. The matrix with bound pep-
tide and peptide RNA complexes was then separated from the
supernatant, the matrix was washed with selection buffer, and
the radioactivity was determined in both fractions. From the
measured values, the no peptide control was subtracted as
background.
Isothermal calorimetry
For calorimetric measurements, a VP-ITC Microcalorimeter
(MicroCal, Northampton, MA) was used. The freshly dena-
tured Spiegelmer and the ligand solutions were degassed in
selection buffer at 37 C; the Spiegelmer was loaded into the
instrument’s sample cell at 10 mM (cell volume, 1.4 ml), and
the ligands were ﬁlled into the injection syringe at 50 mM
(syringe volume, 0.25 ml). Each injection of ligand solution
was 6 s long, with 5 min between injections for complete
equilibration and baseline recovery. The ﬁrst injection had
a volume of 3 ml and the following were 7.5 ml each.
Determination of Spiegelmer inhibitory activity with
calcium mobilization assays
AR42J pancreatic cells were seeded with 6 · 10
4 cells per well
in a black 96-well plate with clear bottom (Greiner) and cul-
tivated overnight at 37 C and 5% CO2 in DMEM supplied
with 20% fetal calf serum, 100 U/ml penicillin and 100 mg/ml
streptomycin. Spiegelmers were incubated with 3 nM sub-
stance P in HBSS, containing 20 mM HEPES, 1 mg/ml
BSA, 5 mM probenecid (HBSS+), in a 0.2 ml low proﬁle
96-well plate for 15–60 min at room temperature or at
37 C. After washing with 200 ml HBSS+,5 0ml of the calcium
indicator dye ﬂuo-4 (10 mM ﬂuo-4, 0.08% pluronic 127 [both
Molecular Probes] in HBSS+) were added to the cells and
incubated for 60 min at 37 C. Thereafter, cells were washed
three times with 180 ml HBSS+. Finally, 90 ml HBSS+ were
added per well.
Measurement of ﬂuorescence signals was accomplished at
an excitation wavelength of 485 nm and an emission wave-
length of 520 nm in a Fluostar Optima multidetection plate
reader (BMG, Offenbach, Germany). For parallel measure-
ment of several samples, wells of one (perpendicular) row
of a 96-well plate were recorded together. First, three readings
with a time lag of 4 s were carried out to determine the base
line; the recording was then interrupted and the plate was
moved out of the instrument. Using a multi-channel pipette,
10 ml of stimulation solution (L-substance P preincubated with
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The plate was then moved back into the instrument and the
measurement continued. In total, 30 recordings with time
intervals of 4 s were performed. For each well, the difference
between maximum ﬂuorescence and base line value was
determined and plotted against L-substance P concentration
or, in the experiments on the inhibition of L-substance
P-induced calcium release by Spiegelmers, against the
Spiegelmer concentration.
RESULTS
Development of an automated in vitro selection protocol
It is well known from the literature that manual selection
schemes are able to yield high-quality aptamers. Therefore,
the system speciﬁcations of the robotic workstation for auto-
mated in vitro selection were set to be as close as possible to
the manual procedures. With this regard, three major problems
had to be tackled.
Prevention of cross-contamination during the selection.
Cross-contamination could be best minimized by using the
MWG RoboAmp robot with its NCC system. A special manip-
ulator opens and closes individual lids on the plasticware
used. Thus, only one single well on the whole robotic work
surface is open at any given time. During thermocycling, no
reusable rubber sealing mat (a major source of possible cross-
contamination) or sealing foil is necessary. NCC-compatible,
lidded reservoir tubes for reagent storage are also available,
which prevent liquid loss or, even worse, dilution of cooled
enzymes by condensing water.
Amplification control. Ampliﬁcation is the part of an in vitro
selection round, which optimally just increases the number of
selected RNA species to an amount that can be used as input
into the next round. In practice, however, the enzymes that are
involved in this process exert additional, unwanted selective
pressure. This frequently leads to the rise of ampliﬁcation
artefacts that are enriched not owing to their afﬁnity to the
target, but because they are good ampliﬁcation substrates. We
have developed a fully automated semi-quantitative PCR pro-
tocol, which not only effectively prevents overcycling during
PCR, but also supplies the researcher with valuable insight
into the status of the selection, thus allowing for optimal
adjustment of selection parameters for the following round.
For this purpose, thermocycling is interrupted three times after
a preset number of PCR cycles (default: 7, 10 and 13 cycles).
Assays for quantiﬁcation of dsDNA with PicoGreen were set
up from PCR aliquots; ﬂuorescent analysis was carried out
immediately. Whenever the ratio of ﬂuorescence (cycled reac-
tions) and ﬂuorescence (non-cycled blank) exceededthe preset
threshold of 2.0, the respective reaction(s) were archived in a
safe storage position before the reaction plate was moved back
to the thermocycler. Hence, the PCRs were cycled only as long
as necessary to obtain enough dsDNA template for the sub-
sequent step of in vitro transcription.
Automated RNA purification. A robot-accessible and robust
procedure had to be developed to remove any spurious sub-
stances from the RNA as a prerequisite to link two subsequent
selection rounds without manual intervention. This is a feature
that would confer enormous ﬂexibility to the automated
process because free choice of buffers for all processes in
which the RNA or dsDNA intermediates might be involved
is extremely valuable. As we intended to select for aptamers
that bind under physiological conditions, low molecular
weight compounds that are present in transcription reaction
mixtures in large amounts, such as NTPs, MgCl2, spermidine
or DTT, had to be removed. Therefore, a vacuum manifold
was designed and constructed that can host disposable, single
Microcon ultraﬁltration devices which retain nucleic acids
of >60 nt in length. After loading the transcription reactions
to the units, applying vacuum to the manifold, and washing
with water, only the macromolecules were retained which
could be easily resuspended in the desired buffer or reaction
mixture.
The course of the selected RNA pool and its intermediates
through different plasticware during two consecutive selection
rounds as well as participation of the workstations in the
overall selection process is depicted in Figure 2A and B.
Automated selection of D-substance P binding
aptamers
The amount of material that can be handled in microtiter plates
by the robot is limited. To assure that the selection process
starts with a huge (>10
14 different molecules) and highly
diverse library, initial selection rounds were carried out manu-
ally. The target concentrations in the manually performed
rounds one and two were 30 mM, in round three 10 mM.
The progress of the following automated selection rounds is
displayed in Figure 3. In rounds 4 and 5, wash volumes
between 18 and 54 column volumes were used with a constant
target concentration of 10 mM of biotinylated D-substance P in
the binding reaction; beginning with round 6, three different
target concentrations were used. In all automated selection
rounds, a mock selection lacking target was processed in
parallel. After two consecutive rounds, the selection strand
with the lowest target concentration which had still exhibited
a clear signal/noise ratio in comparison with the mock was
gel puriﬁed and subjected to the next two selection rounds.
dsDNA resulting from round 14 (14 nM) was ﬁnally custom
cloned and sequenced (Agowa GmbH, Berlin, Germany).
The sequences of 24 clones were determined. Nucleotide
sequences and frequencies of the clones are summarized in
Figure 4A.
Identification of a minimal binding domain
Spiegelmers are composed of mirror-image nucleotides and,
therefore, they have to be synthesized chemically. In order to
ensure high-quality syntheses, Spiegelmer sequences should
be shorter than  60 nt in length. The D-substance P-speciﬁc
aptamer sequences that were obtained from the in vitro selec-
tion experiment had an overall length of 83 nt. Besides the
most frequent sequence A11, only few additional sequences
with point mutations had been enriched. dsDNA templates for
in vitro transcription of different truncated clones were pre-
pared and used to generate radiolabelled truncated transcripts
SUP-A-001(48nt)toSUP-A-004(44nt)(seeFigure4B).Sub-
stance P binding of truncated RNA molecules was assessed in
pull-down assays. As all examined truncated aptamers had
retained substance P binding activity, the shortest sequence
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mentary Figure 2). Accordingly, SUP-A-004 was synthesized
in its mirror-image conﬁguration using L-phosphoramidites.
Secondary structure predictions (minimum free energy con-
formations) were made using the Zuker algorithm with default
parameter settings for A11, SUP-A-001 and SUP-A-004
(Figure 4C) (19).
ITC experiments
The dissociation constant of the Spiegelmer L-SUP-A-
004 substance P complex was determined to be 40 – 9n M
by ITC experiments (data from three independent measure-
ments). A typical binding isotherm is shown in Figure 5A.
L-SUP-A-004 bound to the N-terminal 7 amino acid peptide
A
B
Figure 2. The automated selection process. (A) Course of the selected RNA pool and its intermediates through two consecutive selection rounds. Blackened wells
indicatethepositionswheretheprocessednucleicacidsarelocatedduringtherespectivesteps.Yellowplateswithsimplewells:Thermosprintreactionplates.Black
plates:forfluorescentassays.Whiteconcentriccirclesonredplate:plasticcolumnsforpartitioninginvacuummanifoldL.Whitecirclesonblueplate:ultrafiltration
devices on vacuum manifold R. Step I: adjustment of buffer conditions, RNA denaturing and re-folding, and pre-selection. Step II: incubation of RNA and target,
fishing of RNA target complexes. Step III: partitioning of bound from unbound RNA. Step IV: semi-quantitative RT–PCR. Step V: in vitro transcription. Step VI:
purification of RNA. (B) Robot devices involved in each selection step. Numbers refer to workstations as shown in Figure 1B.
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subpeptide substance P5-11 (Supplementary Figure 1A and
B). Binding was neither observed to the tachykinin neurokinin
A nor to D-substance P (Table 1; Supplementary Figure 1C
and D). Likewise, non-functional control Spiegelmer did not
bind to L-substance P (Supplementary Figure 1E).
In vitro cell assays
In order to prove biological inhibitory activity of L-SUP-A-
004, a cell assay based on substance P sensitive human AR42J
pancreatic cells was carried out.Substance Pbinding toAR42J
cellsleadstoanintracellularcalciumrelease.Afterstimulation
with different concentrations of substance P, a half-maximum
effective concentration of 3 nM (EC50) was determined
(data not shown). While incubating 3 nM substance P with
different concentrations of L-SUP-A-004, the Spiegelmer
shows a dose-dependent inhibition of the stimulatory action
of substance P. The half-maximum inhibition (IC50) was
achieved at an L-SUP-A-004 concentration of  45 nM,
whereas a non-functional control Spiegelmer had no effects
throughout the concentration range tested (Figure 5B).
DISCUSSION
Commercially available robotic systems for biochemical or
biotechnological applications are mostly designed to facilitate
high-throughput analytical pipetting protocols. Thus, they are
perfectly suited for the rapid execution of, preferably small
volume, biochemical assays. In vitro selection, on the other
hand, requires accurate succession of various complex proced-
ures as well as preparative steps, such as afﬁnity chromato-
graphy,enzymaticreactions andpuriﬁcationprotocols.Yields,
which are of no importance in qualitative analytical applica-
tions, are very important for successful execution of an in vitro
selection experiment: sufﬁcient amounts of nucleic acid must
be generated to allow initiation of the respective following
round of selection. At the expense of mere speed, we there-
fore chose a highly ﬂexible single-pipette robotic platform and
equipped it additionally with the necessary periphery to treat
the samples almost exactly as a human researcher would do.
This instrumentation allows execution strategies for the iden-
tiﬁcation of high-quality aptamers while saving precious
reagents at the same time. Throughout the whole automated
in vitro selection process, physiological buffer and temperat-
ure conditions are adjusted and maintained in the binding
reactions. The robotic system described performs two selec-
tion rounds per day and is, therefore, much slower than the six
daily rounds that Cox et al. (5–8) achieve with their system.
However, in Cox’ protocol, time is mainly economized by the
reduction of incubation times, which make up substantially
more than half of the total time per selection round in our
process. In addition, our in vitro selection protocol differs
signiﬁcantly in at least two aspects from the previously pub-
lished automated in vitro selection protocol.
Online monitoring. The progress of our automated in vitro
selection process is controlled through the measurement of
the PCR yield. During every selection round, semi-
quantitative PCRs are automatically performed, which
allow assessment of the amount of nucleic acid that has
bound to the target. As this is always carried out for three
binding reactions containing different amounts of target plus a
non-target control, this facilitates the choice of suited para-
meters for the respective following round. Just like a human
researcher would do, the concentration of target in the binding
reaction is kept as low as possible, which increases the chance
to select binders with maximal afﬁnity to the target. PCR
monitoring, at the same time, helps to control the potential
rise of ampliﬁcation artefacts. Being responsive to the amount
of dsDNA present in every PCR, the system automatically
terminates further thermocycling of the respective reaction
Figure 3. Progress of the in vitro selection against substance P. Rounds
1–3 were carried out manually; in rounds 4 and 5, the target concentration
was 10 mM for all three selection strands while varying the wash volume (CV,
column volumes); rounds 6–15, varied target concentrations while washing
with a fixed wash volume. Starting with round 4, the ratio of fluorescence
intensity with/without polymerase is given.
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Figure 4. Aptamer/Spiegelmersequences. (A) DNAsequencesthat wereobtained after cloningand sequencingthe14th roundof selection. (B) Truncatedversions
of the most frequent clone A11. (C) Secondary structure (minimum free energy conformations) as predicted by mfold (19).
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been generated.
In contrast, Cox et al. tried to avoid overampliﬁcation in
PCR by performing a deﬁned number of 20 cycles in rounds
1–10 and 16 cycles in the following rounds; although this
procedure helps to reduce the risk of unwanted PCR side
reactions, it does not deliver data about the progress of the
selection. Therefore, it is difﬁcult to determine the right time
point to increase the selection stringency by either lowering
the target concentration or intensifying the washing procedure.
Moreover, uncertainty about the selection progress leads to an
increased risk to enrich matrix binders. This can be partly
reduced by constantly enhancing the stringency with
increasing concentrations of salt in the selection buffer (7).
Nevertheless, online monitoring of the PCR provides a
valuable opportunity to react ﬂexibly on the progress of the
selection itself.
Versatility. Introduction of ultraﬁltration into the puriﬁca-
tion protocols of an automated SELEX process allows robust
and highly effective puriﬁcation of RNA from low molecular
weight compounds, such as NTPs, salts or detergents. More-
over, ultraﬁltration allows a free choice of buffer conditions
in every reaction or incubation step. This is a prerequisite
for linking two selection rounds together, especially when
the desired binders have to bind under clearly deﬁned condi-
tions or if special solvents and reagents are incompatible with
subsequent steps of an in vitro selection cycle. This is an issue
if denaturing reagents are used to elute the target-bound RNA
or if a competitive elution scheme using the target itself is
introduced. By ultraﬁltration, even high concentrations of urea
can be successfully separated from the isolated nucleic acids
so that subsequent steps are not negatively affected. Further-
more, even highly sophisticated selection protocols that
involve multiple changes of buffers and conditions (20) are
compatible with our robotic system and have already been
realized (see Supplementary Material). However, a drawback
of every automated process is its restriction to the volume
range, which is determined by the used tools and labware.
In order to maintain the maximum library complexity that
is practically accessible and to make sure not to lose a single
potential good binding sequence, we started the selection
process with a manual selection round. We decided to con-
tinue the selection with two additional manual rounds
because we wanted to be sure that the selection runs stably
before fully relying on the new automated process. Since the
process turned out to be very robust, we are convinced that
it could be started in an earlier round or even right at the
beginning. In our opinion, the latter is only recommendable
ifthetargetisjudgedtobea‘good’SELEXtarget(e.g.heparin
binding protein) and if it can be expected to obtain satis-
factorily binding aptamers even from libraries with lower
complexities.
The identiﬁed Spiegelmer L-SUP-A-004 binds substance P
with adissociationconstant of 40nMat37 C.This resultisa
satisfactory proof that our automated in vitro selection process
is capable of yielding aptamers with equal, if not better, qual-
ities than reported for manual in vitro selection schemes.
Nieuwlandt et al. (16) reported an RNA aptamer to substance
P that was isolated after two consecutive selection schemes
and eventually showed a Kd of 190 nM (at room temperature).
L-SUP-A-004 not only binds to substance P but also inhibits
substance P action in a relevant cell assay. With an IC50 of




Figure 5. Binding and inhibition of substance P by Spiegelmer L-SUP-A-004.
(A) Calorimetric profile of Spiegelmer L-SUP-A-004 binding to substance P
(representative data from one ITC experiment). The dissociation constant was
determined to be  40 nM. (B) Inhibition of substance P-induced AR42J cell
stimulation by L-SUP-A-004 (filled squares) and non-functional control
Spiegelmer (filled circles). The IC50 was determined to be  45 nM at a
stimulatory substance P concentration of 3 nM.
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